JPRN-UMIN000001941已完成未知
Efficacy of Low-dose Landiolol and carvedilol in Patients with Supraventricular Tachycardia after Pulmonary Resections - Efficacy of Landiolol in Patients with Arrhythmias after Pulmonary Resections
Toneyama National Hospital0 个研究点目标入组 40 人开始时间: 2009年5月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
RESULTS; There were no significant differences between the two groups regarding blood pressure before and after medication. Heart rate was reduced immediately in both groups after medication and was significantly lower in the landiolol group than in the control group. The time to restore sinus rhythm was significantly shorter in the landiolol group than in the control group. In none of the subjects with the landiolol infusion was it discontinued because of side effects. CONCLUSION; Low-dose landiolol can be effective quickly and used safely in patients who develop atrial fibrillation after pulmonary resection for lung cancer.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 DiabetesHypertensionType 2 Diabetes MellitusNCT00123604St. Paul Heart Clinic36
尚未招募
4 期
Blood pressure lowering effect of combination therapy of angiotensin receptor blocker (ARB) and Ca antagonist in patients with high risk hypertensioHypertensionJPRN-UMIN000002207Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School40
已完成
3 期
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive PatientsAbdominal ObesityHypertensionNCT00459056St. Paul Heart Clinic25
尚未招募
不适用
oninvasive cardiac output monitoring to optimise therapy for patients with poorly controlled hypertension: a randomised controlled trialCardiovascular - HypertensionHypertensionACTRN12611001289909The Chinese University of Hong Kong202
已完成
不适用
Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics in patients with insufficient blood pressure control with moderate dose of angiotensin receptor blocker and calcium channel blocker.HypertensionJPRN-UMIN000011328Toshio Kushiro170
